Alzheimer's Disease
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Alzheimer's Disease
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Allanson Pantzar McLeod syndrome
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding)
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding)
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Alzheimer's Disease
|
0.900 |
Biomarker
|
disease |
CTD_human |
Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population.
|
10643899 |
1999 |
Hypotension
|
0.400 |
Therapeutic
|
phenotype |
CTD_human |
Abnormal blood pressure recovery during ganglion blockade in diabetic rats.
|
3544871 |
1987 |
Severe Acute Respiratory Syndrome
|
0.320 |
Biomarker
|
disease |
CTD_human |
ACE1 polymorphism and progression of SARS.
|
15381116 |
2004 |
Pneumonia, Viral
|
0.300 |
Biomarker
|
disease |
CTD_human |
ACE1 polymorphism and progression of SARS.
|
15381116 |
2004 |
Staphylococcal Infections
|
0.300 |
Biomarker
|
group |
CTD_human |
Activity of serum angiotensin converting enzyme in septic pigs treated with intrapulmonary corticosteroid.
|
8186310 |
1994 |
Staphylococcus aureus infection
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity of serum angiotensin converting enzyme in septic pigs treated with intrapulmonary corticosteroid.
|
8186310 |
1994 |
Heart failure
|
0.600 |
Biomarker
|
disease |
CTD_human |
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
|
18586661 |
2008 |
Heart Failure, Right-Sided
|
0.310 |
Biomarker
|
disease |
CTD_human |
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
|
18586661 |
2008 |
Left-Sided Heart Failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
|
18586661 |
2008 |
Myocardial Failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
|
18586661 |
2008 |
Heart Decompensation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
|
18586661 |
2008 |
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
CTD_human |
All three possible combinations of the ACE gene insertion/deletion polymorphism were found in gastric cancer cell lines, i.e., the DD- (AGS, MKN28), the II- (MKN45) and the ID-genotype (N87).
|
18059164 |
2007 |
Alzheimer's Disease
|
0.900 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Presenile dementia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Familial Alzheimer Disease (FAD)
|
0.310 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
Liver carcinoma
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
|
16328049 |
2006 |
Beryllium Disease
|
0.310 |
Biomarker
|
disease |
CTD_human |
Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease.
|
10194187 |
1999 |